{"version":"1.0","provider_name":"Department of Medicine","provider_url":"https:\/\/www.med.unc.edu\/medicine","author_name":"Lillian Harbison","author_url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/lilharbi\/","title":"Joseph Eron on New HIV Prevention Breakthrough | Department of Medicine","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"DuCrnS2G4U\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/joseph-eron-on-new-hiv-prevention-breakthrough\/\">Joseph Eron on New HIV Prevention Breakthrough<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.med.unc.edu\/medicine\/news\/joseph-eron-on-new-hiv-prevention-breakthrough\/embed\/#?secret=DuCrnS2G4U\" width=\"600\" height=\"338\" title=\"&#8220;Joseph Eron on New HIV Prevention Breakthrough&#8221; &#8212; Department of Medicine\" data-secret=\"DuCrnS2G4U\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/02\/joe-eron-e1615927778476.jpeg","thumbnail_width":199,"thumbnail_height":237,"description":"Joseph Eron, M.D., the Herman and Louise Smith Distinguished Professor of Medicine at UNC School of Medicine and director of the Clinical Core at the UNC Center for AIDS Research, is spotlighting the potential of lenacapavir, a new FDA-approved, twice-yearly injectable medication for HIV prevention. In clinical trials, lenacapavir showed 99.9% effectiveness\u2014surpassing daily PrEP pills.Dr. &hellip; Read more"}